MP
VMD icon

Mangrove Partners’s Viemed Healthcare VMD Stock Holding History

Mangrove Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$763K Buy
82,876
+10,933
+15% +$91K 0.06% 132
2025
Q4 		$535K Buy
+71,943
New +$493K 0.04% 154

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Mangrove Partners's VMD Position: Q1 2026 in Review

Mangrove Partners increased its Viemed Healthcare (VMD) stake by 15% in Q1 2026, buying an estimated $91K and bringing the position to 82,876 shares worth $763K. The position accounts for 0.06% of the portfolio, ranked #132.

Mangrove Partners first reported a position in VMD in Q4 2025 and has held it in 2 quarters since. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Mangrove Partners held 82,876 shares of Viemed Healthcare worth $763K as of Q1 2026.
  • Mangrove Partners bought 10,933 Viemed Healthcare shares in Q1 2026, an estimated $91K.
  • Viemed Healthcare made up 0.06% of Mangrove Partners's portfolio in Q1 2026, its #132 holding.
  • Mangrove Partners first reported a position in Viemed Healthcare in Q4 2025 and has held it in 2 quarters since.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Mangrove Partners's 13F filing for Q1 2026, filed 15 May 2026.